Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ArQule Inc (NASDAQ:ARQL)

1.14
Delayed Data
As of Mar 24
 -0.05 / -4.20%
Today’s Change
1.13
Today|||52-Week Range
2.17
-9.52%
Year-to-Date
No recent news for ArQule Inc.

Today’s Trading

Previous close1.19
Today’s open1.19
Day’s range1.13 - 1.19
Volume383,391
Average volume (3 months)171,886
Market cap$81.1M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-31.31%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-58.10%
P/E ratioNM
Price/Sales18.65
Price/Book3.43

Competitors

 Today’s
change
Today’s
% change
CXRXConcordia Internatio...+0.03+2.23%
ATNMActinium Pharmaceuti...-0.02-1.38%
SYNSynthetic Biologics ...-0.02-2.43%
GTXIGTX Inc-0.10-1.96%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$4.7M
Annual profit (last year)-$22.7M
Net profit margin-482.44%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Paolo Pucci
President, COO, Secretary &
General Counsel
Peter S. Lawrence
Corporate headquarters
Burlington, Massachusetts

Forecasts


Search for Jobs